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Abstract—Deep learning fostered a leap ahead in automated
skin lesion analysis in the last two years. Those models, however,
are expensive to train and difficult to parameterize. Objective: We
investigate methodological issues for designing and evaluating
deep learning models for skin lesion analysis. We explore ten
choices faced by researchers: use of transfer learning, model
architecture, train dataset, image resolution, type of data aug-
mentation, input normalization, use of segmentation, duration
of training, additional use of Support Vector Machines, and
test data augmentation. Methods: We perform two full factorial
experiments, for five different test datasets, resulting in 2560
exhaustive trials in our main experiment, and 1280 trials in our
assessment of transfer learning. We analyze both with multi-way
analyses of variance (ANOVA). We use the exhaustive trials to
simulate sequential decisions and ensembles, with and without
the use of privileged information from the test set. Results
main experiment: Amount of train data has disproportionate
influence, explaining almost half the variation in performance.
Of the other factors, test data augmentation and input resolution
are the most influential. Deeper models, when combined, with
extra data, also help. — transfer experiment: Transfer learning
is critical, its absence brings huge performance penalties. —
simulations: Ensembles of models are the best option to provide
reliable results with limited resources, without using privileged
information and sacrificing methodological rigor. Conclusions
and Significance: Advancing research on automated skin lesion
analysis requires curating larger public datasets. Indirect use of
privileged information from the test set to design the models
is a subtle, but frequent methodological mistake that leads to
overoptimistic results. Ensembles of models are a cost-effective
alternative to the expensive full-factorial and to the unstable
sequential designs.
Index Terms—Skin lesion analysis, deep learning, experimental
design, model parameterization, cross dataset.
I. INTRODUCTION
While deep learning is well-established as the gold standard
for image classification, it poses challenges to adapt for new
tasks, due to a profusion of hyperparameters. Automated skin
lesion analysis is no exception, with a state of the art that
has sharply improved since the adoption of those models, but
which still lacks reliable recommendations for their design.
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Recent works on skin lesion classifiers present novel deep-
learning models, each representing a given choice of hy-
perparameters. Those works’ primary goal is improving the
classification metrics on a given skin lesion dataset. Each
paper compares a handful of models (representing different
hyperparameterizations), concluding that some choice — for
example, the use of a given deep-learning architecture — is
better than the alternatives. Different authors recommend dif-
ferent hyperparameters (Section II), an apparent contradiction
that arises because each work evaluates a limited number of
factors/parameters spanning a small number of models.
What literature currently lacks — and this work intends to
provide — is a systematic evaluation of the hyperparameters
of deep learning for skin lesion analysis. We propose an
exhaustive evaluation of ten factors faced when designing
deep-learning models. We explore the variations of those
factors in two full factorial designs. Our main experiment eval-
uates nine factors, for five different test datasets, resulting in
29×5 = 2560 treatments. Our assessment of transfer learning
evaluates eight factors for five datasets, with 28 × 5 = 1280
treatments. We analyze those results using multi-way analyses
of variance (ANOVA), to obtain decisions that generalize
across datasets.
Our work is unprecedented in existing art, both in the scope
of the experiments, and the rigor of the statistical analyses.
Because the full factorial design used in our ANOVAs is too
expensive for most practical contexts, we also simulate two
alternative designs: the traditional sequential optimization (a
single factor at a time) and ensembles of models. We show that
the latter provides the best performance, at reasonable costs.
This paper follows our participation at the International Skin
Imaging Collaboration — ISIC 2017 Challenge [8]. At the
time, with a strategy of aggressively optimizing our models,
we were ranked first in melanoma classification [27], with an
area under the receiver operating characteristic curve (AUC) of
0.874. Here we have different goals, focusing on understanding
which factors of the deep learning approach most contributed
for boosting performances.
The contributions of the paper are:
• A main evaluation of nine factors affecting the design of
deep learning for skin lesion analysis, together with their
cross interactions up to the third level;
• A quantitative appraisal of the importance of transfer
learning, in perspective with seven of the nine factors
analyzed in the main experiment;
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2• A demonstration of the ability of simple ensemble solu-
tions to provide good results, without sacrificing method-
ological rigor;
• A critique of hyperparameter optimization, demonstrating
that the customary procedure of optimizing hyperparam-
eters and evaluating techniques on the same dataset leads
to overoptimistic results;
• State-of-the-art AUCs in all three classification tasks of
the ISIC Challenge 2017/Part 3. While the focus of
this paper is not on increasing metrics; those results
showcase both the power of ensembles, and the ability
to obtain state of the art results while following strict
methodological constraints;
• Finally, our entire source code is available, and our pro-
cedures are explained step-by-step, from the acquisition
of the data, until the generation of the tables and graphs
of this paper1. We are committed to make this work as
reproducible as technically feasible.
We organized the remaining text as follows: we discuss the
recent state of the art in Section II, and very briefly overview
our participation on ISIC Challenge 2017. We detail our goals,
materials, and methods in Section III. Experimental results and
analyses appear in Section IV. Finally, we review and discuss
the main findings in Section V.
II. SURVEY OF RECENT TECHNIQUES
In this Section, we survey existing art on automated skin
lesion analysis. We focus on works published since 2016, when
literature took a sharp turn towards deep learning. For relevant
previous literature [6], [18], we refer the interested reader to
more comprehensive surveys [14], [22]. We assume that the
reader has passing familiarity with deep learning and its issues
— if needed, we refer the reader to a complete overview [21].
Recent works on skin lesion classifiers have the primary
goal of improving classification metrics on a given skin lesion
dataset. Because of the staggering number of design choices
for deep learning, each author chooses a limited number of
hyperparameters to evaluate, spanning a handful of prospective
novel models. Usually, a paper is considered fit for publication
when at least one of those prospective models shows better
performance metrics than recent techniques.
In the next paragraphs, we discuss the hyperparameters
raised most frequently by existing literature on deep-learning
skin analysis. For each hyperparameter, we illustrate how dif-
ferent authors have taken different stances, indicating whether
authors’ opinions tend to converge or diverge on their choices.
Existing works either train deep networks from scratch [19],
[28], [31]; or reuse the weights from pre-trained networks
[9], [12], [16], [23], [26], [39], in a scheme called transfer
learning. Transfer learning is usually preferred, as it alleviates
the main issue of deep learning for skin lesion analysis: way
too small datasets — most often comprising a few thousand
samples. (Contrast that with the ImageNet dataset, employed
to evaluate deep networks, with more than a million samples.)
Training from scratch is preferable only when attempting
1https://github.com/learningtitans/data-depth-design
new architectures, or when avoiding external data due to le-
gal/scientific issues. Menegola et al. [26] explain and evaluate
transfer learning for skin lesion analysis in more detail.
In this paper, in our main experiment of hyperparameteriza-
tion of deep learning, all treatments employ transfer learning.
We also perform an experiment to quantify the importance of
transfer learning, in which half the treatments employ transfer
learning, and half do not.
Whether using transfer or not, works vary widely in their
choice of deep-learning architecture, from the relatively shal-
low (for today’s standards) VGG [15], [23], [26], [39], mid-
range GoogLeNet [12], [16], [35], [37], [39], until the deeper
ResNet [4], [9], [16], [24], [27] or Inception [10], [12], [27].
On the one hand, more recent architectures tend to be deeper,
and to yield better accuracies; on the other hand, they require
more data and are more difficult to parameterize and train.
Although high-level frameworks for deep learning have sim-
plified training those networks, a good deal of craftsmanship
is still involved. In this work, we contrast two architectures:
ResNet-101-v2 [17], and Inception-v4 [33]. Both are very
deep and show outstanding performance on ImageNet, but
Inception-v4 is considerably deeper and bigger than ResNet-
101-v2.
Data augmentation is another technique used to bypass
the need for data, while also enhancing networks’ invariance
properties. Augmentation creates a myriad of new samples
by applying random distortions (e.g., rotations, crops, resizes,
color changes) to existing samples. Augmentation provides
best performance when applied to both train and test samples,
but only the most recent skin lesion analysis works follow that
scheme [4], [10], [26]–[29]. Train-only augmentation is still
very common [11], [12], [15], [23], [35], [37], [39].
In this work, we evaluate two augmentation distortion
setups (TensorFlow/Slim’s default for each network, and an
attempt to customize it for skin lesions). We always apply
augmentation to the train samples, but evaluate the impact of
applying or not augmentation for test samples.
Works based on global features or bags of visual words
often preprocess the images (some recent works using deep
learning do it as well) to reduce noise, remove artifacts (e.g.,
hair), enhance brightness and color, or highlight structures [1],
[19], [24], [31], [36], [38]. The deep-learning ethos usually for-
goes that kind of “hand-made” preprocessing, relying instead
on networks’ abilities to learn those invariances — with the
help of data augmentation if needed.
On the other hand, segmentation as preprocessing is com-
mon on deep-learning for skin lesion analysis [28], [37],
sometimes employing a dedicated network to segment the
lesion before forwarding it to the classification network [9],
[11], [39]. Those works usually report improved accuracies. In
this work, we also evaluate the impact of using segmentation
to help classification.
If ad-hoc preprocessing (e.g., hair removal) is atypical
in deep-learning, statistical preprocessing is very common.
Many networks fail to converge if the expected value of
input data is too far from zero. Learning an average input
vector during training and subtracting it from each input is
standard, and performing a comparable procedure for standard
3deviations is usual. The procedure is so routine, that with rare
exceptions [20], [27], researchers do not even mention it. In
this work, we evaluate the impact of two image normalization
schemes: TensorFlow/Slim’s default for each network, and an
attempt to customize it for skin lesions.
Deep network architectures can directly provide the clas-
sification decisions, or can provide features for the final
classifier — often Support Vector Machines (SVM). Both
the former [12], [16], [23], and the latter [9], [15], [26],
[31] procedures are readily found for skin lesion analysis.
We evaluate those choices of adding or not an SVM layer.
Also common, are ensemble techniques, which fuse the
results from several classifiers into a final decision [4], [10],
[16], [24], [27].
As shown above, the literature on automated skin lesion
analysis is vast: even the limited scope chosen for this survey
comprises more than a dozen works. Making comparisons
across those techniques was, until very recently, next to
impossible due to poorly documented choices of datasets,
splits, implementation details, or even evaluation metrics [14].
The ISIC Challenge [8] has sharply improved that scenario,
by providing standards for data and metrics, and by requiring
participants to publish working notes.
A subtler way ISIC Challenge served the community was by
clearly separating validation and test datasets, and by keeping
test datasets secret until all evaluations were over. When test
sets are open, researchers have a strong tendency to optimize
hyperparameters on test (hyperoptimize on test, for short).
Hyperoptimizing on test is not the same as overfitting the
training: the latter is a technical shortcoming in which one
overadjusts one’s parameters (or hyperparameters) to train (or
validation) data, while the former is a methodological error
in which one adjusts one’s hyperparameters using test data.
Hyperoptimizing on test is also different than directly train–
test contamination — mixing train and test samples, or using
statistics from the test set in the model — a crude methodolog-
ical blunder that most practitioners avoid. Hyperoptimizing on
test is a subtle methodological error in which one indirectly
uses information from the test set, by, for example, designing,
refining and evaluating different models over a test set, picking
the best one and reporting its results in that same test set [32].
Since the whole process may stretch over weeks or months,
researchers fail to realize they are using privileged information
to improve the model. As we will discuss, hyperoptimizing on
test leads to overoptimistic estimations of performance.
As discussed in Section I, existing art lacks a systematic
evaluation of the hyperparameters above. The present work
intends to fill this gap.
A. ISIC Challenge 2017
We documented our participation in Parts 1 and 3 of ISIC
Challenge 2017 in our working notes [27]. In this section, we
briefly summarize that participation, our findings, and contrast
our aims then and now.
Our team has been working on skin lesion analysis since
early 2014 [13], and has been employing deep learning with
transfer learning for that task since 2015 [5]. On the other
hand, we were tackling skin lesion segmentation for the very
first time. Our team reached 1st place in melanoma classi-
fication (AUC = 0.874), 3rd place at keratosis classification
(AUC = 0.943), and 3rd place in overall melanoma/keratosis
classification (mean AUC = 0.908). We also reached 5th place
in skin lesion segmentation (Jaccard score = 0.754). The
organizers published a comprehensive summary of the entire
challenge [8].
The experiments presented here are inspired by the findings
we made during the challenge, but this paper takes different
directions, especially regarding methodology. If during the
challenge we tempered scientific rigor with the sportive desire
to win, here we stress only the former: this work does not focus
on maximizing AUCs, but on broader issues of experimental
design and validation for the proposed methods.
III. MATERIALS AND METHODS
In this section we explain in detail the methodology em-
ployed in this paper, comprising the factors present in our
experimental design, the hardware/software infrastructure used
to run the experiments, the statistical design of the experi-
ments, the datasets employed, and the deep-learning models
evaluated.
Our first — and more practical — goal is an exhaustive
evaluation of the design of deep-learning models for skin
lesion analysis. We focused on ten hyperparameters (a choice
motivated by their importance in existing literature, as ex-
plained in Section II). Each of those hyperparameters becomes
a factor in our experimental design (Table I).
Most of those factors are not particular to skin lesion
analysis, but are relevant for all image classifiers using deep
learning. However, a preoccupation with resolution (c), aug-
mentation customization (d), and segmentation (f) makes more
sense for skin lesion analysis — or at least for medical images
in general — than for general-purpose tasks, like ImageNet.
Our second, more philosophical, goal is discussing method-
ological issues in the design and evaluation of classification
models, especially those which, like skin lesion analysis, aim
at medical applications. We are far from the first to point
out [32], [34] that the common practice of meta-optimizing a
technique on the same test set used to evaluate the technique
leads to over-optimistic results. In this paper, we showcase
that effect as we cross-analyze the results in five different test
sets.
A. Software and Hardware
We ran the experiments on a cluster of Ubuntu Linux
machines, on a variety of NVIDIA GPUs, including Ti-
tan X Maxwell, Titan X Pascal, and Tesla K40. We built
the classification models on Python/TensorFlow v.1.3. using
the Slim framework. Slim provides ready-to-use models for
ResNet-101-v2 and Inception-v4, which we used, with slight
adaptations. The statistical analyses ran in R.
In this text we aimed to provide the details needed to
understand all results; for complete reproducibility, we provide
the end-to-end pipeline, from the raw data to the tables and
figures, at our code repository.
4TABLE I
FACTORS IN OUR EXPERIMENTAL DESIGNS, WITH CORRESPONDING LEVELS
Symbol Factor Levels
a Model ResNet-101 v2 versus Inception v4
b Train dataset Train split of ISIC Challenge 2017 versus Full: Level 1 + ISIC Archive + U. of Porto PH2 + U. of Edinburgh Dermofit
c Input resolution Pre-augmentation resolution — 299×299 pixels (305×305 if using segmentation) versus 598×598 pixels
d Train augmentation TensorFlow/Slim’s default versus Level 1 + rotations = on, fast mode = off, minimum area = 0.20
e Input normalization TensorFlow/Slim’s default versus Subtract mean of samples’ pixels
f Segmentation No segmentation information versus Segmentation pre-encoded at input
g Training length Short (about half the length of Full) versus Full (30k batches for ResNet / 40k batches for Inception; batch size = 32)
h SVM decision layer Absent versus Present
i Test augmentation post-deep No (decision on single non-augmented sample) versus Yes (decision on average of 50 random-augmented samples)
j Test dataset Split of Train/Full vs. Validation of ISIC Chall. ’17 vs. Test of ISIC Chall. ’17 vs. EDRA/Dermoscopic vs. EDRA/Clinical
t Transfer learning Training from scratch (weights initialized at random) vs. Transfer from ImageNet (checkpoint published by Tensorflow/Slim)
B. Experimental Design
The main experimental design was a two-level full fac-
torial design for nine of the ten factors mentioned above
(a–i), for each one of the five test datasets (j), resulting in
29 × 5 = 2560 treatments evaluated. We ran a second experi-
ment to evaluate the impact of transfer learning, evaluating
seven factors (a–e, g, i, t), and fixing (f) as no segmentation
and (h) as SVM layer absent, resulting in 28 × 5 = 1280
treatments evaluated. In all experiments, we used the AUC as
main metric. Following the ISIC Challenge 2017, we use the
mean AUC between the melanoma-vs-all and the keratosis-vs-
all as the measured outcome in all experiments.
The analysis for both experiments was a classical multi-
way ANOVA, in which the test datasets entered as one of
the factors. That choice highlights our aim to make decisions
that generalize across datasets, in contrast to maximizing the
performance for a particular dataset.
ANOVA provides both a significance analysis (p-value), and
a partition of the variance, which allows to roughly estimate
the relative importance/influence of each factor, or combina-
tions of factors. For effect size/explanatory power, we use
the η2 measure, which is the ratio of the variances (sums-of-
squares), extensively used due to its simplicity. The ANOVA
table of the main experiment is summarized in Table III and
explored in the next section. We also employed correlograms
to highlight issues relating to the choice of the test dataset,
and performance metric (Fig. 6).
Most of the time, our full factorial designs are too costly to
use — thus our next set of experiments, exploring ensemble
techniques, helps in more practical situations. We evaluated
a straightforward ensemble, which just pools the decision
of several classifiers, and showed that it provides very good
performances, without the costs of a full design.
We also simulated the most common procedure employed
by researchers and practitioners: sequential optimization of hy-
perparameters, in which one starts from a given configuration
of hyperparameters, selects one of them to evaluate, commits
to the best results, and proceeds to evaluate the next. Although
that procedure is very fast (it allows optimizing the nine factors
our main design in just 18 experiments), it is sub-optimal in
comparison to ensembles.
Finally, we showed that the customary procedure of opti-
mizing the hyperparameters in the same test set used to
evaluate the technique leads to overoptimistic results in both
the ensemble and the sequential design.
Details and results of all procedures appear in Section IV.
C. Data
Due to deep-learning greediness for data, we sought all
high-quality publicly available (for free, or for a fee) sources
to compound our dataset:
1) ISIC 2017 Challenge [8], the official challenge dataset,
with 2,000 dermoscopic images (374 melanomas, 254
seborrheic keratoses, and 1,372 benign nevi).
2) ISIC Archive, with over 13,000 dermoscopic images.
3) Dermofit Image Library [3], with 1,300 clinical images
(76 melanomas, 257 seborrheic keratoses).
4) PH2 Dataset [25], with 200 dermoscopic images (40
melanomas).
5) EDRA Interactive Atlas of Dermoscopy [2], with 1,000+
clinical cases (270 melanomas, 49 seborrheic keratoses),
each with at least two images (dermoscopic, and close-up
clinical).
We used essentially the same data sources we employed
during the ISIC 2017 challenge, except for the no longer avail-
able dataset created by the Department of Medical Informatics,
RWTH Aachen University (cited in our report [27] as “IRMA
Dataset”). Even with that exclusion, the new dataset grew, due
to better matching diagnostics among the sources (instead of
dropping the doubtful cases).
Besides that matching, which we performed with a thesaurus
of the terms used in the different datasets, we also annotated
images by case, by aliases (same image with different names),
and by near-duplicates (two almost-copies of the same lesion).
When creating the train and test sets, we barred any cases,
aliases, or near-duplicates from splitting across sets.
Data sources affect the train and test datasets. For the train
dataset (factor b), we contrasted (1) using only the official train
split of the ISIC Challenge 2017 dataset, to (2) joining the train
split of the ISIC Challenge, the ISIC Archive, the Dermofit
Library, and the PH2 Dataset and extracting from that full
dataset a train split. For the test dataset (factor j), we contrasted
(1) an internal test split extracted from our full dataset; (2)
the official validation split and (3) the official test split of
ISIC Challenge 2017; (4) the dermoscopic images and (5) the
clinical images of the EDRA Interactive Atlas of Dermoscopy.
5TABLE II
SUMMARY OF THE TRAIN AND TEST SETS.
Type Melanoma Nevus Keratosis
ISIC Challenge 2017 train split 374 1372 254
Full train (composition of datasets) 1227 10124 710
Internal test split from full 135 3129 89
ISIC Challenge 2017 validation split 30 78 42
ISIC Challenge 2017 testing split 117 393 90
EDRA Atlas of Dermoscopy (each version) 518 1154 95
Table II summarizes the final assembled sets. Figure 1 shows
some samples of the datasets.
Melanoma Melanoma Nevus Keratosis
Dermofit
EDRA/Clinic
EDRA/Dermato
ISIC Archive
PH2
Fig. 1. Samples of skin lesion images. Rows: datasets used in this work.
Columns: types of lesions. The first two rows are clinical images; the others
are dermoscopic images. Note that the EDRA samples are the same lesion
captured in each of the techniques. The PH2 dataset does not have Keratosis
lesions.
D. Models
For the main experiment, we always employed pre-trained
models that proved successful for the ImageNet challenge,
loading the weights from checkpoints published in TensorFlow
repository. For the transfer experiment, we contrasted those
with the same models initialized with random weights.
To evaluate the choice of the model (factor a) we con-
trasted two architectures: ResNet-101-v2 [17], and Inception-
v4 [33], using the reference implementation available in Ten-
sorFlow/Slim v1.3.
In this paper, segmentation was used only as an ancillary
input for classification (factor f). For the ISIC Challenge 2017,
we had used a segmentation network based on the work
of Ronneberger et al. [30] and Codella et al. [7]. For this
work, we streamlined that model, reducing the number of
parameters, removing the fully-connected and Gaussian-noise
layers, and adding batch-normalization and dropout layers.
The new model2 is faster to train and occupies much less
disk space. We trained the segmentation models on the same
images as their corresponding classification models.
Because of the lack of literature consensus on how to use
segmentation for skin lesion analysis, we opted for schemes
2https://github.com/learningtitans/isbi2017-part1
with minimal changes to both data and networks. We pre-
evaluated two candidates: pixel-wise multiplying the input
RGB images by the segmentation masks versus pre-encoding
the four planes (Red, Green, Blue and mask) into three planes,
keeping the rest of the networks unchanged. For the full
design, we only considered the latter, which appeared more
promising on those preliminary tests.
Pre-encoding the masks required slightly adapting ResNet
and Inception, by adding the pre-encoding adapter layers. For
both ResNet/Inception we added three convolutional layers
before the input, two layers with 32 filters, and a third with 3
filters. All convolutional layers used 3×3 kernels and stride of
1. Since ResNet-101-v2 and Inception-v4 models require input
images of 299×299 pixels, the adapter layer took 305×305-
pixel images, to account for the 2 border pixels lost at each
convolutional layer.
IV. RESULTS AND DISCUSSION
In this Section we show and discuss the results of the exper-
iments introduced in Section III-B. For easier understanding,
we organized the extensive results into five subsections: hy-
perparameterization of deep learning for melanoma screening,
importance of transfer learning, pitfalls of sequential designs,
power of ensembles, and pitfalls of hyperoptimizing on test.
A. Deep-learning hyperparameterization
As explained, the main experiment was a full factorial
design with nine two-level factors (a–i), and five test datasets
(factor j). We used a classical multi-way ANOVA with the
mean AUC for melanoma and keratosis as the measured
outcome (with the small technicality of taking the logit of
that measure, since, when working with rates, the logit helps
to fulfill ANOVA’s assumption of Gaussian residuals). We
considered all main effects, and up to 3-way interactions.
We considered higher-order interactions unlikely and assigned
them to the residuals.
Table III shows a summary of main experiment’s ANOVA,
with the symbols for the factors and interactions on the first
column, and the names of the main factors on the second. The
remaining columns show the outcomes of the test. The most
important columns are p-value, which measures statistical
significance, and explanation (%), which measures effect-
size/explanatory power. The p-value is inferred, as usual, from
the F-statistic of ANOVA, while the explanatory power uses
the η2 measure.
We present the absolute explanation (considering the entire
table) for reference, but our analysis is focused on the relative
explanation, which ignores the choice of the test set (j) and
the residuals. The reason for ignoring those is that they are not
actual choices for designing a new model; therefore, relative
explanations indicate better the relative importance of choices
to practitioners.
The original full table contained all main effects, and up
to 3-way interactions. However, not surprisingly, 126 of the
resulting 176 lines were non-significant interactions, which
were omitted here. We also left out those interactions with
6TABLE III
SELECTED LINES FROM THE 176-LINE ANOVA TABLE; MOST OF THE OMITTED LINES (126) HAD P-VALUES ≥ 0.05. ABSOLUTE EXPLANATION BASED
ON η2-MEASURE, RELATIVE EXPLANATION IGNORES RESIDUALS AND CHOICE OF TEST DATASET (J).
Explanation (%) Best AUC (%) Worst AUC (%)
Factor p-value Absolute Relative Treatment Mean Treatment Mean
a Model architecture <0.001 0 1 resnet 84 inception 83
b Train dataset <0.001 5 46 full 85 challenge 81
c Input resolution <0.001 1 5 598 84 299–305 82
d Data augmentation 0.17 0 0 default 83 custom 83
e Input normalization 0.001 0 0 default 83 erase mean 83
f Use of segmentation <0.001 0 2 no 84 yes 83
g Duration of training 0.003 0 0 full 83 half 83
h SVM layer <0.001 0 4 no 84 yes 83
i Augmentation on test <0.001 1 12 yes 84 no 82
j Test dataset <0.001 75 full.split 96 edra.clinical 66
a:b <0.001 1 8 inception/full 86 inception/challenge 80
a:f <0.001 0 2 resnet/no 84 inception/yes 82
b:e <0.001 0 2 full/default 86 challenge/default 80
b:j <0.001 2 full/full.split 98 chall/edra.clinical 63
h:j <0.001 0 no/full.split 97 yes/edra.clinical 65
i:j <0.001 0 yes/full.split 97 no/edra.clinical 65
a:b:d <0.001 0 2 inception/full/custom 86 inception/challenge/custom 78
a:d:e <0.001 0 2 resnet/custom/default 85 inception/custom/default 81
a:f:j <0.001 0 resnet/yes/full.split 97 inception/yes/edra.clinical 65
b:d:e <0.001 0 1 full/custom/default 86 challenge/custom/default 79
c:e:f <0.001 0 1 598/default/no 86 299–305/default/yes 82
Residuals — 12
relative explanations lower than 1%, even if significant. With
the notable exception of the customized data augmentation
(d), all main effects were significant, but most of their relative
explanations were small.
The analysis of the relative explanation shows an unsurpris-
ing, but still disappointing result: the performance gains (b) are
almost wholly due to the usage of more data. Other than data,
the most important factor was the use of data augmentation
on test (d). We performed it, as usual, by taking the test
image, generating a number (in our case, 50) of augmented
samples exactly like in training, collecting the prediction for
each of the samples, and pooling the decisions (in our case,
by taking the average prediction). Although not surprising for
the literature of deep learning, that finding is relevant for the
literature of skin lesion analysis, where many works still forgo
augmentation in the test.
Most of the findings tended to confirm the (limited) ob-
servations we made during the ISIC Challenge 2017, with
two notable exceptions. Input resolution (c), which we deemed
unimportant during the challenge, turned out to have a non-
negligible effect. That result is particularly interesting, because
we used a very rough form of augmented resolution, by
inputting high-resolution images to the augmentation engine,
but still feeding normal-resolution crops to the network. On the
other hand, the use of an SVM decision layer (h), which we
considered advantageous during the Challenge turned out to
have a large-effect... only negative! Globally, ANOVA shows
it is better not to use the SVM.
Normalization (e) and training duration (g) showed tiny
(<1%), but still significant positive effects. The choice for
those factors must consider their very different costs: adding
normalization costs next to nothing, both in implementation
complexity and in training time. Training duration doubled
the already many-hours-long training times.
As usual, most of the interactions were not significant,
and even the ones that were, had effect sizes too small to
be worth noting. A notable exception was the interaction
between model architecture and train dataset (a:b), whose 8%
of relative explanation was bigger than most main effects.
Model choice alone favors the simplest ResNet over Inception,
but the combination of Inception with the full dataset is
so advantageous that it offsets that effect. We had already
observed, informally, this synergy between more data and
deeper models during the Challenge.
The most disappointing result was the use of segmentation,
which was more than unhelpful, harmful. This result, how-
ever, is contingent on our choice for adding segmentation to
classification.
B. The importance of transfer learning
We ran a second full factorial design, with seven of the ten
factors of the main experiment (a–e, g, i, j), fixing factors
(f) and (h), and adding a factor to evaluate the presence
versus absence of transfer learning (factor t). The new factorial
design, with 28×5 = 1280 treatments, shows transfer learning
as critical for performance: it explains (favorably) 14.7% of the
absolute variation, and a whopping 62.8% of the relative vari-
ation of performance (computing those metrics the same way
as the in the main experiment, i.e., excluding the residuals, and
the choice of test dataset and its interactions from the relative
variation), with high significance (p-value below 0.001). We
omit the ANOVA table for concision. Those results reinforce
previous findings on the importance of transfer learning for
skin lesion analysis [26].
7C. The pitfalls of sequential designs
As mentioned, full factorial designs are way too expensive
for the majority of situations. The most common procedure
is the exact opposite: taking a single factor to optimize, and
performing a couple of experiments on that factor alone, keep-
ing all others fixed (starting from a combination considered
reasonable). Once a factor is decided, one commits to it and
takes the next to optimize, until the procedure is complete.
We evaluate the impact of such sequential procedure, sim-
ulating it using the measurements on the full design. We take,
at random, both the starting treatment and the sequence of
factors to test. For factors not yet optimized, the level is given
by the starting treatment. Each factor is optimized in turn, by
comparing the performance of the alternative treatments on
the full-factorial data of a chosen hyperoptimization dataset.
The outcome of a single simulation is the performance of the
optimized treatment on a chosen measurement dataset. We use
the mean keratosis/melanoma AUC as the performance metric.
Fig. 3 shows the results for pairs of hyperoptimization ×
measurement datasets, where we perform 100 simulations for
each pair. The actual measurements appear as black dots, and
the violin plots show their estimated density, while the big red
dot shows their mean. The most important observation here is
the large variability of the results, visible in both the dispersion
of the actual observations (black dots) and the spread of the
estimated distribution (violin plots). That variability showcases
the instability of the sequential procedure, which depends both
on the order in which one optimizes the factors, and on the
starting value for them.
Another notable observation is the (unrealistic) advantage
of hyperoptimizing and measuring on the same dataset: not
only do we get higher averages, but also a smaller variability.
The advantage of hyperoptimizing and measuring on splits of
the same dataset is more subtle, but present. That phenomenon
will be discussed in more detail in Section IV.
D. The power of ensembles
The expense of the full factorial design, the instability
of the sequential procedure, and the limited correlation of
performances across datasets seem to leave few options to
practitioners. Fortunately, single-model schemes are seldom
used today, and ensembles of several models help to alleviate
those issues.
We simulated different ensemble strategies, by pooling the
predictions of models present in our full design. We evaluate
three pooling strategies: average, max, and extremal. Average-
and max-pooling work as usual. Extremal pooling takes, from
the list of values being pooled, the value most distant from 0.5
— it may be seen as an “hypothesis-invariant” max-pooling. In
all cases, after pooling, we re-normalize the probability vector
to ensure it sums up to one. Half the models in the full design
entered as candidates, and we discarded in this experiment
the models with the SVM layer, due to issues in making their
probabilities commensurable with the deep-only models.
Fig. 4 shows the main results. Average-pooling was, by
far, the best choice for pooling the decision. Such clear-
cut advantage came as a surprise for us, as max-pooling
often outperforms average-pooling in related tasks. If no other
information is available, simply average-pooling randomly
selected models is a reasonable strategy.
The use of dozens — even hundreds — of models may
sometimes be justified in critical tasks (like medical decisions),
but training and evaluating so many deep networks is cumber-
some. Fortunately, as Fig. 5 shows, a handful of models seem
to work just as well. The results shown here are the “good
news” part of this paper: we can escape the expense of the full
factorial design, and the instability of the sequential designs,
by averaging a dozen or so models with parameters chosen
entirely at random — although the random ensembles start
very unstable, they soon converge to a reasonable model, in
average and variability. If we decide to perform a full factorial,
there is good news too: the best models learned in one dataset
seem to be informative to compose the ensembles in other
datasets, allowing to get top performances with very small
ensembles.
Here, again, the unfair advantage of optimizing (selecting
the models for the ensemble) and measuring performance
on the same dataset appears. The advantage is small but
systematic for the test split of ISIC (Fig. 5a); it is much more
apparent for the challenging collection of clinical images of
EDRA Atlas (Fig. 5b).
E. The pitfalls of hyperoptimizing on test
As a final experiment, we made two simulations of “new”
submissions to the ISIC 2017 Challenge. The first simulates
a blind procedure, mimicking the conditions of the challenge
(limited information about the validation split, no information
whatsoever about the test split). In that simulation, we assume
a full factorial experiment performed only on our internal
validation split, and keep the 32 best models (as measured
in that split). We then test 32 incremental ensembles on the
ISIC validation set, finding that the ensembles with 15 or 16
models have the best performance. We commit to the ensemble
with 15 models and do one evaluation of that ensemble on
the ISIC test split, finding AUCs of 0.895 (melanoma), 0.967
(keratosis), and 0.931 (combined). To put those numbers in
perspective, in the actual competition the best AUCs were,
respectively, 0.874, 0.965, and 0.911 (obtained by different
participants).
We also simulated a privileged procedure, hyperoptimizing
without restraint on the ISIC Challenge test split itself. We
use the full design on the ISIC Test split to select the 32 best
models, and then test 32 incremental ensembles, handpicking
the best result for melanoma and for keratosis. We find AUCs
of 0.916 (melanoma), 0.970 (keratosis), and 0.943 (combined).
Again, to get a better grasp of the difference, consider that
the 2.p.p. increase on the melanoma AUCs is larger than the
difference between the 1st and the 4th teams ranked in the
2017 Challenge.
The results above are reinforced by additional correlation
analysis with the full factorial experiment (Fig. 6), which
highlight the correlations (a) among results on different test
datasets; and (b) among different metrics. To keep the scatter
plots directly interpretable, instead of taking the logit of the
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Fig. 2. Correlograms with pair-wise correlation analyses. Sets appear on the diagonal; upper matrices show the scatter plots, and lower matrices show the
Spearman correlation of each pair of sets. On lower matrices, numbers and solid circles’ areas show the mean estimates, and dashed circles’ areas show the
95%-confidence bounds. Non-significant estimates appear without the circles. All numbers in %, negative correlations are in red.
rates, we dealt with the non-linearity by using Spearman’s ρ
instead of Pearson’s r as correlation measure.
The correlogram on Fig. 6a employs the same metric as the
ANOVA, the mean melanoma/keratosis AUC used as main
metric at the ISIC 2017 Challenge. The test dataset names
appear in the diagonal, along with the maximum and minimum
AUCs obtained for the 512 variations of the full design on that
dataset. The scatter plots in the upper-triangular matrix follow
the usual construction for correlograms. The lower-triangular
matrix displays the Spearman’s ρ’s: the mean estimate appears
as the printed numeral and as the area of the solid circle; the
bounds of the 95%-confidence interval appear as the area of
the internal and external dashed circles. Negative correlations
appear in red.
The correlation between different test datasets is far from
perfect. That is, perhaps, obvious, but must be stressed, since
it reveals that naively hyperoptimizing a model on one test set
will not necessarily generalize to other data. The relationship
between splits of different datasets is more subtle. Note how
the correlation between the validation and the test splits of
ISIC 2017 Challenge, and the dermoscopic and clinical splits
of EDRA have the highest correlations. This suggests that
results measured on splits of the same dataset may not wholly
generalize over data of the same type obtained on different
conditions. Both phenomena show how hyperoptimizing on
test gives unwarranted advantages, leading to overoptimistic
assessments. The correlogram on Fig. 6b employs a different
metric, the melanoma AUC, and leads to the same conclusions.
In order to better understand the metrics, we plotted the
correlogram on Fig. 6c, considering only the results for the
test split of the ISIC Challenge. Different metrics appear in
the diagonal: average precision, area under the ROC curve,
sensitivity (true positive rate), and specificity (true negative
rate), for both melanoma and keratosis. The interpretation of
the plots, numerals, circles, and colors is the same as above.
This correlogram is interesting for showing that many
metrics have correlations that are not that big. Particularly
noteworthy is the specificity, which has not only a negative
correlation with sensitivity (as expected), but also a negative
or very small correlation with most of the other metrics. Such
behavior is not particular to the choice of test dataset, as we
illustrate in Fig. 6d, which shows the same correlogram for
the EDRA Dermoscopic test dataset, with similar results.
V. CONCLUSIONS
In this paper, we performed an extensive investigation of
the hyperparameterization of deep learning for automated
melanoma screening. Our finds both validate with a rigorous
experimental design previous intuitions present in existing art,
and bring novel perspectives to the design of such models.
The pitfalls of hyperoptimizing on test: Although the
problems with the privileged procedure become clear when we
contrast it side-by-side with the blind procedure, hyperoptimiz-
ing on test is widely present machine-learning literature (we
are often guilty ourselves). It does not result from researchers’
desire to cheat, but from our natural tendency to exploit
scarce existing data as much as possible. Salzberg has warned
researchers about the dangers of “repeated tuning” since 1997;
his work [32] is often cited, but the issue is still far from
solved.
Avoiding that pitfall requires a very strong commitment,
which researchers seem unable to keep. That reinforces the
importance of regular curated challenges — like the ISIC
Challenge — in which the test set is withheld at least until
the evaluations are over. The ImageNet competition is perhaps
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(b) Simulated sequential design on EDRA Atlas clinical images.
Fig. 3. Simulation of the sequential optimization of hyperparameters, considering all nine factors (a–i) as the main full factorial. Factors optimized on the
dataset shown on the horizontal axis, and performance (mean melanoma/keratosis AUC) measured on the dataset indicated on the captions. For each case, we
run 100 simulations, with random optimization sequences and starting points. The violin plots show the kernel density estimation of the actual data (black
dots) and the large red dot shows their mean.
the best example of the extraordinary impact of having such
a curated competition every year.
Our findings explain, in part, why performances observed in
practice fall much shorter of the numbers we get in our labs.
In a single round of experiments, analyzing only two levels for
nine factors, the unwarranted advantage of hyperoptimizing on
test is already notable. In actual research, with many rounds
of experiments over dozens of factors and hundreds of levels,
the gap may be much wider.
Deep-learning hyperparameterization: in our main re-
sults, we evaluate 2560 different models, showing that the
amount of data alone explains almost half the variability in
performance. That reinforces the deep-learning creed on the
“unreasonable power of data” and has important consequences
for the skin lesion analysis community: in order to move
research forward, we need to curate larger shared datasets.
The ISIC Archive is an essential step in that direction — but
it would have to grow almost tenfold to match the largest
(private) dataset reported in the literature [12].
Despite the predominance of data, other factors appeared
relevant. The most noteworthy is, perhaps, the use of data
augmentation on test samples. The use of deeper models in
combination with extra data, also appeared as an important
advantage. Increased resolution — even in a very limited
scheme — was also advantageous.
Notable negative results were the use of segmentation to
help classification, and the use of an extra SVM Layer.
The negative result on segmentation is the most surprising,
and needs further exploration, since literature reports many
different ways to incorporate segmentation into classification,
often with improved performances. We would like to explore
that theme in future works, exhaustive in that particular scope.
The importance of transfer learning: our evaluation of
transfer learning, comprising the evaluation of 1280 models,
reinforce its importance, showing that the use of the technique
can explain more than 60% of the relative variation of perfor-
mance.
The pitfalls of sequential designs: we demonstrate the
disadvantages of the widespread procedure of sequentially
optimizing the hyperparameters one by one, after picking an
arbitrary starting value for them. Our results show that such
procedure is very unstable, depending at random both on the
starting point and the sequence of optimization.
The power of ensembles: fortunately, our experiments on
the power of ensembles bring encouraging news, providing
reliable performances, without neither the expense of the full
factorial design, nor the instability of the sequential opti-
mization. Even a simple accumulation of enough randomly-
sampled models was sufficient to provide adequate perfor-
mance. Learning the best models on one dataset, however,
helps to select the best ensembles for other datasets. Ensem-
bles appear as a promising avenue for future explorations. In
future works, we would like to design and evaluate techniques
more sophisticated than pooling the decisions of the models,
like model stacking, or boosting.
ACKNOWLEDGMENT
We gratefully acknowledge the donation of a Tesla K40
and two TITAN X GPUs by NVIDIA Corporation, used
in this work. We thank Fabio Perez, Micael Carvalho, and
Fillipe D. M. de Souza, for help in revising the manuscript.
10
chosen by auc on internal test split chosen at random
50 100 150 200 250 50 100 150 200 250
50
60
70
80
90
100
number of models
a
u
c 
(%
)
tested on: int. test split isic/val. isic/test edra/dermosc. edra/clinical
pooling by: avg extreme max
Fig. 4. Evaluation of ensemble strategies, by pooling the prediction of a given number of partial models using average-, max-, or extremal-pooling. Left:
cumulative effect of adding partial models, starting with the best (as evaluated by the internal test split). Right: same plot, with models randomly shuffled.
(Best viewed in color.)
sorted by:
isic/test
isic/validation
internal test split
random50
60
70
80
90
100
4 8 12 16
number of models
a
u
c 
(%
)
(a) Ensembles tested on ISIC 2017/testing.
sorted by:
edra/clinical
edra/dermosc.
internal test split
random50
60
70
80
90
100
4 8 12 16
number of models
a
u
c 
(%
)
(b) Ensembles tested on EDRA Atlas/clinical.
Fig. 5. Detailed analysis of ensembles, contrasting the dataset used to choose the models (shown as different curves) in order to optimize the results measured
on the test dataset indicated in the captions. We sampled 10 different random ensembles. (Best viewed in color.)
We thank Prof. M. Emre Celebi for kindly providing the
machine-readable metadata of the EDRA Interactive Atlas of
Dermoscopy and for the help in revising the first draft.
FUNDING
E. Valle and M. Fornaciali were partially funded by Google
Research Awards for Latin America 2016 & 2017; E. Valle
is also partially funded by a CNPq PQ-2 grant (311905/2017-
0). A. Menegola was funded by CNPq. S. Avila is partially
11
68 = auc min
auc max = 99
same−dataset
test split
65
68 = auc min
auc max = 96
cross−dataset
ISIC/val
70 91
63 = auc min
auc max = 94
cross−dataset
ISIC/test
67 70 76
67 = auc min
auc max = 89
cross−dataset
EDRA/dermo
56 64 69 82
54 = auc min
auc max = 75
cross−dataset
EDRA/clinic
(a) Correlogram of mean melanoma/keratosis AUC across test datasets.
78 = auc min
auc max = 99
same−dataset
test split
52
68 = auc min
auc max = 94
cross−dataset
ISIC/val
59 80
56 = auc min
auc max = 91
cross−dataset
ISIC/test
57 54 65
65 = auc min
auc max = 88
cross−dataset
EDRA/dermo
24 38 49 57
48 = auc min
auc max = 75
cross−dataset
EDRA/clinic
(b) Correlogram of melanoma AUC across test datasets.
25 = min
max = 78
melanoma
avg. prec.
92
56 = min
max = 91
melanoma
auc
82 79
0 = min
max = 72
melanoma
sensitivity
19 27 67
80 = min
max = 100
melanoma
specificity
88 89 75 22
35 = min
max = 88
keratosis
avg. prec.
85 90 72 22 94
69 = min
max = 97
keratosis
auc
61 68 73 50 66 62
0 = min
max = 81
keratosis
sensitivity
20 6 10 42 21 19 51
86 = min
max = 100
keratosis
specificity
(c) Correlogram of metrics on ISIC 2017 Test dataset across metrics.
47 = min
max = 79
melanoma
avg. prec.
93
65 = min
max = 88
melanoma
auc
61 54
0 = min
max = 74
melanoma
sensitivity
10 13 68
75 = min
max = 100
melanoma
specificity
78 69 60 5
8 = min
max = 67
keratosis
avg. prec.
75 63 55 4 87
61 = min
max = 93
keratosis
auc
28 11 41 27 44 48
0 = min
max = 59
keratosis
sensitivity
42 50 16 16 49 37 41
82 = min
max = 100
keratosis
specificity
(d) Correlogram of metrics on EDRA Dermoscopic dataset across metrics.
Fig. 6. Correlograms with pair-wise correlation analyses. Sets appear on the diagonal; upper matrices show the scatter plots, and lower matrices show the
Spearman correlation of each pair of sets. On lower matrices, numbers and solid circles’ areas show the mean estimates, and dashed circles’ areas show the
95%-confidence bounds. Non-significant estimates appear without the circles. All numbers in %, negative correlations are in red.
funded by Google Research Awards for Latin America 2018,
FAPESP (2017/16246-0) and FAEPEX (3125/17). This project
is partially funded by CNPq Universal grant (424958/2016-3).
RECOD Lab. is partially supported by diverse projects and
grants from FAPESP, CNPq, and CAPES. The funding sources
had no involvement in the data acquisition, study design, result
analysis, or in the manuscript writing.
REFERENCES
[1] Q. Abbas, M. Emre Celebi, I. F. Garcia, and W. Ahmad, “Melanoma
recognition framework based on expert definition of abcd for dermo-
scopic images,” Skin Research and Technology, vol. 19, no. 1, 2013.
[2] G. Argenziano, H. P. Soyer, V. De Giorgi, D. Piccolo, P. Carli,
M. Delfino et al., “Dermoscopy: a tutorial,” EDRA, Medical Publishing
& New Media, 2002.
12
[3] L. Ballerini, R. B. Fisher, B. Aldridge, and J. Rees, “A color and texture
based hierarchical K-NN approach to the classification of non-melanoma
skin lesions,” in Color Medical Image Analysis, 2013, pp. 63–86.
[4] L. Bi, J. Kim, E. Ahn, and D. Feng, “Automatic skin lesion analysis
using large-scale dermoscopy images and deep residual networks,” arXiv
preprint arXiv:1703.04197, 2017.
[5] M. Carvalho, “Transfer schemes for deep learning in image classifica-
tion,” Master’s thesis, University of Campinas, 2015.
[6] M. E. Celebi, H. A. Kingravi, B. Uddin, H. Iyatomi, Y. A. Aslandogan,
W. V. Stoecker, and R. H. Moss, “A methodological approach to the
classification of dermoscopy images,” Computerized Medical Imaging
and Graphics, vol. 31, no. 6, pp. 362–373, 2007.
[7] N. Codella, J. Cai, M. Abedini, R. Garnavi, A. Halpern, and J. R. Smith,
“Deep learning, sparse coding, and svm for melanoma recognition in
dermoscopy images,” in International Workshop on Machine Learning
in Medical Imaging, 2015, pp. 118–126.
[8] N. C. Codella, D. Gutman, M. E. Celebi, B. Helba, M. A. Marchetti,
S. W. Dusza, A. Kalloo, K. Liopyris, N. Mishra, H. Kittler et al.,
“Skin Lesion Analysis Toward Melanoma Detection: A Challenge at the
2017 International Symposium on Biomedical Imaging (ISBI), Hosted
by the International Skin Imaging Collaboration (ISIC),” arXiv preprint
arXiv:1710.05006, 2017.
[9] N. C. Codella, Q.-B. Nguyen, S. Pankanti, D. Gutman, B. Helba,
A. Halpern, and J. R. Smith, “Deep learning ensembles for melanoma
recognition in dermoscopy images,” IBM Journal of Research and
Development, vol. 61, no. 4, pp. 5:1–5:15, 2017.
[10] T. DeVries and D. Ramachandram, “Skin lesion classification us-
ing deep multi-scale convolutional neural networks,” arXiv preprint
arXiv:1703.01402, 2017.
[11] I. G. Dı´az, “Incorporating the knowledge of dermatologists to convolu-
tional neural networks for the diagnosis of skin lesions,” arXiv preprint
arXiv:1703.01976, 2017.
[12] A. Esteva, B. Kuprel, R. A. Novoa, J. Ko, S. M. Swetter, H. M. Blau,
and S. Thrun, “Dermatologist-level classification of skin cancer with
deep neural networks,” Nature, vol. 542, no. 7639, pp. 115–118, 2017.
[13] M. Fornaciali, S. Avila, M. Carvalho, and E. Valle, “Statistical learning
approach for robust melanoma screening,” in Conference on Graphics,
Patterns and Images (SIBGRAPI), 2014, pp. 319–326.
[14] M. Fornaciali, M. Carvalho, F. V. Bittencourt, S. Avila, and E. Valle,
“Towards automated melanoma screening: Proper computer vision &
reliable results,” arXiv preprint arXiv:1604.04024, 2016.
[15] Z. Ge, S. Demyanov, B. Bozorgtabar, M. Abedini, R. Chakravorty,
A. Bowling, and R. Garnavi, “Exploiting local and generic features
for accurate skin lesions classification using clinical and dermoscopy
imaging,” in IEEE International Symposium on Biomedical Imaging
(ISBI), 2017, pp. 986–990.
[16] B. Harangi, “Skin lesion detection based on an ensemble of deep
convolutional neural network,” arXiv preprint arXiv:1705.03360, 2017.
[17] K. He, X. Zhang, S. Ren, and J. Sun, “Identity mappings in deep residual
networks,” in European Conference on Computer Vision, 2016, pp. 630–
645.
[18] H. Iyatomi, H. Oka, M. E. Celebi, M. Hashimoto, M. Hagiwara,
M. Tanaka, and K. Ogawa, “An improved internet-based melanoma
screening system with dermatologist-like tumor area extraction algo-
rithm,” Computerized Medical Imaging and Graphics, vol. 32, no. 7,
pp. 566–579, 2008.
[19] X. Jia and L. Shen, “Skin lesion classification using class activation
map,” arXiv preprint arXiv:1703.01053, 2017.
[20] J. Kawahara, A. BenTaieb, and G. Hamarneh, “Deep features to classify
skin lesions,” in IEEE International Symposium on Biomedical Imaging,
2016, pp. 1397–1400.
[21] Y. LeCun, Y. Bengio, and G. Hinton, “Deep learning,” Nature, vol. 521,
no. 7553, pp. 436–444, 2015.
[22] G. Litjens, T. Kooi, B. E. Bejnordi, A. A. A. Setio, F. Ciompi,
M. Ghafoorian, J. A. der Laak, B. G. Clara, and I. Sa´nchez, “A survey
on deep learning in medical image analysis,” Medical Image Analysis,
vol. 42, pp. 60–88, 2017.
[23] A. R. Lopez, X. Giro-i Nieto, J. Burdick, and O. Marques, “Skin lesion
classification from dermoscopic images using deep learning techniques,”
in IEEE International Conference on Biomedical Engineering (BioMed),
2017, pp. 49–54.
[24] K. Matsunaga, A. Hamada, A. Minagawa, and H. Koga, “Image clas-
sification of melanoma, nevus and seborrheic keratosis by deep neural
network ensemble,” arXiv preprint arXiv:1703.03108, 2017.
[25] T. Mendonc¸a, P. M. Ferreira, J. S. Marques, A. R. Marcal, and J. Rozeira,
“PH2 A dermoscopic image database for research and benchmarking,”
in IEEE Engineering in Medicine and Biology Society, 2013, pp. 5437–
5440.
[26] A. Menegola, M. Fornaciali, R. Pires, F. V. Bittencourt, S. Avila,
and E. Valle, “Knowledge transfer for melanoma screening with deep
learning,” in IEEE International Symposium on Biomedical Imaging,
2017, pp. 297–300.
[27] A. Menegola, J. Tavares, M. Fornaciali, L. T. Li, S. Avila, and
E. Valle, “RECOD Titans at ISIC Challenge 2017,” arXiv preprint
arXiv:1703.04819, 2017.
[28] E. Nasr-Esfahani, S. Samavi, N. Karimi, S. M. R. Soroushmehr, M. H.
Jafari, K. Ward, and K. Najarian, “Melanoma detection by analysis of
clinical images using convolutional neural network,” in IEEE Engineer-
ing in Medicine and Biology Society, 2016, pp. 1373–1376.
[29] F. Perez, C. Vasconcelos, S. Avila, and E. Valle, “Data augmentation for
skin lesion analysis,” in ISIC Skin Image Analysis Workshop, 2018.
[30] O. Ronneberger, P. Fischer, and T. Brox, “U-Net: Convolutional net-
works for biomedical image segmentation,” in Medical Image Comput-
ing and Computer Assisted Intervention, 2015, pp. 234–241.
[31] S. Sabbaghi, M. Aldeen, and R. Garnavi, “A deep bag-of-features model
for the classification of melanomas in dermoscopy images,” in IEEE
Engineering in Medicine and Biology Society, 2016, pp. 1369–1372.
[32] S. L. Salzberg, “On comparing classifiers: Pitfalls to avoid and a rec-
ommended approach,” Data Mining and Knowledge Discovery, vol. 1,
no. 3, pp. 317–328, 1997.
[33] C. Szegedy, S. Ioffe, V. Vanhoucke, and A. A. Alemi, “Inception-v4,
inception-resnet and the impact of residual connections on learning,”
AAAI Conference on Artificial Intelligence, pp. 4278–4284, 2017.
[34] A. Torralba and A. A. Efros, “Unbiased look at dataset bias,” in IEEE
Conference on Computer Vision and Pattern Recognition, 2011, pp.
1521–1528.
[35] C. N. Vasconcelos and B. N. Vasconcelos, “Increasing deep learning
melanoma classification by classical and expert knowledge based image
transforms,” arXiv preprint arXiv:1702.07025, 2017.
[36] P. Wighton, T. K. Lee, H. Lui, D. I. McLean, and M. S. Atkins,
“Generalizing common tasks in automated skin lesion diagnosis,” IEEE
Transactions on Information Technology in Biomedicine, vol. 15, no. 4,
pp. 622–629, 2011.
[37] X. Yang, Z. Zeng, S. Y. Yeo, C. Tan, H. L. Tey, and Y. Su, “A
novel multi-task deep learning model for skin lesion segmentation and
classification,” arXiv preprint arXiv:1703.01025, 2017.
[38] T. Yoshida, M. E. Celebi, G. Schaefer, and H. Iyatomi, “Simple and
effective pre-processing for automated melanoma discrimination based
on cytological findings,” in IEEE International Conference on Big Data,
2016, pp. 3439–3442.
[39] L. Yu, H. Chen, Q. Dou, J. Qin, and P.-A. Heng, “Automated melanoma
recognition in dermoscopy images via very deep residual networks,”
IEEE Transactions on Medical Imaging, vol. 36, no. 4, pp. 994–1004,
2017.
